首页> 美国卫生研究院文献>Journal of Assisted Reproduction and Genetics >Levonorgestrel hormone releasing intrauterine system (Mirena®) as a contraceptive in egg donors: case report
【2h】

Levonorgestrel hormone releasing intrauterine system (Mirena®) as a contraceptive in egg donors: case report

机译:左炔诺孕酮激素释放子宫内系统(Mirena®)作为卵子捐赠者的避孕药具:病例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report the safe use of levonorgestrel hormone releasing intra uterine system (Mirena®) as a contraceptive in egg donors during a treatment cycle. In the first case report, a 29-year-old egg donor using the Mirena coil for contraception and two egg recipients, aged 41 years and 32 years respectively underwent standard IVF treatment, oocyte retrieval in the egg donor and in vitro fertilization followed by embryo transfer in the recipient. The outcome of IVF cycle using donor eggs was satisfactory with successful pregnancy in the egg recipient. The second case involved a 34-year-old egg donor using the Mirena coil and a 44-year-old recipient. Our findings suggest that egg donors can safely use the (Mirena®) as a contraceptive device during treatment, without compromising follicular development and oocyte quality.
机译:我们报告了在治疗周期中安全使用左炔诺孕酮激素释放子宫内系统(Mirena®)作为卵子供体的避孕方法。在第一例病例报告中,使用Mirena线圈进行避孕的29岁卵子供体和分别为41岁和32岁的两名卵子接受了标准的IVF处理,卵子供体的卵母细胞回收和体外受精,然后进行了胚胎转移接收者。使用供体卵的体外受精周期的结果在受卵者成功怀孕后令人满意。第二例涉及一名使用Mirena卷的34岁卵子供体和一名44岁受体。我们的发现表明,卵子捐献者可以在治疗过程中安全地使用(Mirena®)作为避孕工具,而不会损害卵泡发育和卵母细胞质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号